Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by jwalliscaon Jun 30, 2020 12:43am

183 Views

Post# 31206227

Level II at close 29 June 2020

Looks like the thinness continues: Buyers move Bids up to chase the Asks.

jwall

Number of Shares		Bid Price
147,500 shares	147,500	0.270
28,000 shares	28,000	0.265
26,500 shares	26,500	0.260
12,000 shares	12,000	0.255
22,000 shares	22,000	0.250
17,500 shares	17,500	0.245
10,000 shares	10,000	0.240
2,500 shares	2,500	0.235
14,000 shares	14,000	0.230
17,500 shares	17,500	0.220


Ask Price	Number of Shares
0.280	33,000	33,000 shares
0.285	6,000	6,000 shares
0.290	57,500	57,500 shares
0.295	10,000	10,000 shares
0.300	68,000	68,000 shares
0.315	43,500	43,500 shares
0.320	30,500	30,500 shares
0.325	40,000	40,000 shares
0.335	10,000	10,000 shares
0.340	28,000